Latest / Pharmacy Podcast Network / NASP 2024 Annual Meeting LIVE ReCap Show Part Four (FINALE) | NASP Specialty Pharmacy Podcast
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 0:24Speaker 2: Welcome back to the Pharmacy Podcast Networks coverage of the
- 0:27Speaker 2: NASP twenty twenty four. We're thrilled to be back interviewing
- 0:31Speaker 2: specialty pharmacy leaders with our special four part series covering
- 0:34Speaker 2: the annual meeting and expo held in Nashville from October
- 0:37Speaker 2: sixth through the ninth. As the official press and media
- 0:40Speaker 2: partner for NASP, we're here to bring you the latest
- 0:43Speaker 2: insights and highlights from this important gathering. This year, industry
- 0:47Speaker 2: thought leaders and healthcare veterans from across the nation united
- 0:50Speaker 2: to discuss the future of specialty pharmacy in the evolving
- 0:53Speaker 2: patient journey. We'd like to thank our sponsor JB Consulting
- 0:56Speaker 2: for supporting the PPN's coverage of the NASP twenty twenty four.
- 1:00Speaker 2: Here's our final part of the four part.
- 1:02Speaker 3: Series, Sean Jensen here at the NASP twenty twenty fourth.
- 1:06Speaker 4: So good to see you, Okay, so good to see you, ton.
- 1:08Speaker 3: All right, you're returning and you've been part of NASP
- 1:13Speaker 3: for a while. I kind of want to just before
- 1:15Speaker 3: we get into the tech because I love talking technology
- 1:19Speaker 3: with you. Talk to us about the association and the
- 1:22Speaker 3: need for this in the need where especially keeps accelerating,
- 1:27Speaker 3: keeps changing.
- 1:28Speaker 4: Yeah, I mean, this is.
- 1:29Speaker 5: The only association you know dedicated to the pharmacies. There's
- 1:33Speaker 5: just been such an energy this year too. I don't know,
- 1:35Speaker 5: is it is it because we're in Nashville.
- 1:37Speaker 3: I'm not sure you.
- 1:38Speaker 5: Know what's so special here, But you know, Sheila and
- 1:40Speaker 5: her team just done such a great job as always,
- 1:42Speaker 5: and this is probably the best conference yet so far.
- 1:44Speaker 3: For some of the sessions that you've shouted out that
- 1:48Speaker 3: you're really looking forward to to diving deeper into do
- 1:52Speaker 3: tie back to technology, no surprise, JB Consulting. So talk
- 1:57Speaker 3: to us about those ones that you're most interested in.
- 2:00Speaker 4: Well, yeah, there's been a lot about ai as.
- 2:02Speaker 5: Everyone's always talking about one that wasn't technology but was
- 2:05Speaker 5: really really fascinating. I just got out of the Tennessee
- 2:07Speaker 5: Innovation Joe Huntsman from Fountain RX was.
- 2:11Speaker 6: There talking about it.
- 2:12Speaker 4: One of the nicest guys you can meet in the industry.
- 2:14Speaker 4: Super brilliant as well.
- 2:16Speaker 5: But yeah, no, the pharmacist role expansion that just happened
- 2:19Speaker 5: in Tennessee.
- 2:20Speaker 4: They could prescribe.
- 2:22Speaker 5: You know, there's seven state senators and our senators and
- 2:25Speaker 5: congressmen in the state that are all pharmacists.
- 2:27Speaker 4: So just you know, really really awesome scene down here.
- 2:29Speaker 5: And I think the only people I've seen as many
- 2:31Speaker 5: Tennessees is probably Pittsburgh last night.
- 2:34Speaker 4: At the at the Steelers game at the bar.
- 2:36Speaker 5: I mean, it was pretty much if you couldn't anywhere
- 2:38Speaker 5: without gombing into a Steelers fan or someone from Pittsburgh.
- 2:41Speaker 5: No surprise, specialty pharmacy, but no, I mean there's a
- 2:44Speaker 5: lot of great technology tracks, and the cell gene therapy
- 2:48Speaker 5: track that they did yesterday, I don't know if you're
- 2:50Speaker 5: calling it out, but really good idea to break that
- 2:52Speaker 5: out into its own track. It's just been so much interest,
- 2:54Speaker 5: and everyone's been asking about that for so long. So
- 2:57Speaker 5: I've actually been enjoying a lot of the non technical
- 2:58Speaker 5: stuff this week as always, but now there's been a
- 3:02Speaker 5: lot of great content outside of technology too.
- 3:05Speaker 3: The AI point it still needs to be demystified from
- 3:10Speaker 3: a lot of people when they say that they're not
- 3:12Speaker 3: quite sure where the context is. I understand it because
- 3:15Speaker 3: I'm hanging out in it. I mean, we see that
- 3:17Speaker 3: there's now prompted texts that are now going to patients
- 3:22Speaker 3: and follow up for certain therapies, taking the data that
- 3:25Speaker 3: is being speech grabbed, the transcripts being put into the notes,
- 3:30Speaker 3: and then of course it's reading it and it's contextualizing
- 3:33Speaker 3: where some of the responses come back. What is some
- 3:37Speaker 3: of the things I can't help, but since you're standing
- 3:39Speaker 3: here at the neasp's booth, I got to ask you
- 3:42Speaker 3: at least one tech thing, but talk to me about
- 3:45Speaker 3: more application of using AI in specialty pharmacy specifically.
- 3:49Speaker 5: Yes, we're actually we were talking about this yesterday. We
- 3:51Speaker 5: had the crossover panel with the Technology Committee and the Law.
- 3:54Speaker 4: Committee, and we had a couple of us.
- 3:56Speaker 5: We're talking about, you know, pushing AI forward, adopting it,
- 3:59Speaker 5: and especially this specialty side, and we had the attorneys
- 4:02Speaker 5: kind of pushing back and telling us why, you know,
- 4:04Speaker 5: the regulations and what some of the concerns would be.
- 4:06Speaker 5: But I think, you know, a big misconception people are
- 4:09Speaker 5: having is confusing automation with AI, and I think right now,
- 4:13Speaker 5: in the here and now, AI tools are being used
- 4:16Speaker 5: to help with automation, like you said, you know, like
- 4:20Speaker 5: reading notes, uh, speech to text like ocr all the
- 4:24Speaker 5: things that AI can do, they're being used to automate,
- 4:28Speaker 5: you know, task it's not so much like the AI
- 4:30Speaker 5: is thinking and.
- 4:31Speaker 6: Doing a whole lot.
- 4:32Speaker 5: That's the next step that they're trying to evolve to.
- 4:33Speaker 5: And I think when you talk about you know, I
- 4:36Speaker 5: don't want to say back end, back office task, but
- 4:38Speaker 5: some of the pharmacists techt some of that stuff, you know,
- 4:41Speaker 5: some of that could.
- 4:41Speaker 4: Be automated with you know, some AI with automation.
- 4:45Speaker 5: Once you get into the clinical side, obviously, that's where
- 4:46Speaker 5: there's a lot more sensitivity and that's what remains to
- 4:49Speaker 5: be seeing what's going to happen there.
- 4:51Speaker 3: All right, So NASP twenty twenty five in Denver, Colorado
- 4:58Speaker 3: High Mile So we're going to see there. Oh yeah,
- 5:00Speaker 3: always absolutely, all right. We really appreciate you helping the
- 5:06Speaker 3: Pharmacy Podcast Network out with some of our own back
- 5:09Speaker 3: end and technology that you're healthily building for us. I
- 5:11Speaker 3: think that's something special that JV Consulting does. What's the
- 5:15Speaker 3: best way to reach out to the organization If someone
- 5:17Speaker 3: wants more information on a special special program or something
- 5:21Speaker 3: in technology that they're having a difficulty getting through or over.
- 5:24Speaker 5: Yeah, I can go to our website Jvconsulting dot com
- 5:27Speaker 5: or someone could connect with me CHEONL.
- 5:28Speaker 4: Jensen on LinkedIn. I always love to talk to anyone.
- 5:30Speaker 3: Appreciate excellent, Thank you, Sean, awesome, thanks Ton, appreciate it.
- 5:37Speaker 3: You know, the American Pharmacists Association and the next Gen
- 5:41Speaker 3: Pharmacist leaders have reached out to so many of the
- 5:45Speaker 3: other associations and have built these new collaboratives. And it's
- 5:50Speaker 3: so nice to see rafaol Senyez here at the NASP
- 5:55Speaker 3: twenty twenty four being on the show. We're so proud
- 5:58Speaker 3: to be your podcast affiliate. Welcome to the show.
- 6:03Speaker 7: Thank you to thanks for having me. It's raphiles signs.
- 6:05Speaker 7: It's like sub signs.
- 6:06Speaker 3: With the rophile signs.
- 6:08Speaker 6: No worry door.
- 6:09Speaker 7: We're very happy to be here. Apha is a crowd
- 6:12Speaker 7: supporter and pardner with NAESP. We invite that to come
- 6:16Speaker 7: to our meetings. We come to theirs. We proudly advertise
- 6:18Speaker 7: and make sure that we are supportive in whatever way
- 6:21Speaker 7: we can of our pharmacy brothers and sister organizations. And
- 6:26Speaker 7: so we're all pulling together, right. We're all one big,
- 6:29Speaker 7: one big family and happy to leave them together, our
- 6:32Speaker 7: ex together, all right.
- 6:37Speaker 3: So from the APHA's perspective, and you have so many
- 6:41Speaker 3: tentacles to policy developers, and how are we helping to
- 6:47Speaker 3: redefine specialty pharmacy in comparison to the other sectors of pharmacy,
- 6:53Speaker 3: which take sometimes a lot more documentation, a lot more handholding,
- 6:57Speaker 3: a lot more payment manipulation or whatever it takes. How
- 7:02Speaker 3: does the APHA help to kind of interconnect those policymakers
- 7:07Speaker 3: to help them understand that it is there's a big
- 7:11Speaker 3: difference between the sectors of pharmacy.
- 7:14Speaker 7: Absolutely, So the very first thing that we do is
- 7:17Speaker 7: we always lead with the member's voice. So anything APHA
- 7:21Speaker 7: does has to directly relate back to a member value set.
- 7:28Speaker 7: So specialty pharmacy is very near and dear to a
- 7:31Speaker 7: lot of our members. In fact, we have a specialty
- 7:34Speaker 7: pharmacy owner on our board, Stephen Carroll, who helps to
- 7:37Speaker 7: inform us on the proper direction that APHA should take
- 7:41Speaker 7: with regard to specialty pharmacy. Otherwise, we hear directly from
- 7:46Speaker 7: our members and we point our advocacy machinery in the
- 7:50Speaker 7: right direction based on what our members are looking for.
- 7:52Speaker 6: But some of these things.
- 7:53Speaker 7: Are very obvious, very bread and butter thing.
- 7:55Speaker 8: Right, So the.
- 7:56Speaker 6: Pharmacy needs to be reiversed.
- 7:58Speaker 7: We have to look at the way ppms are looking
- 8:00Speaker 7: that specialty pharmacy products and services. Are payers reimbursing specialty
- 8:05Speaker 7: pharmacists for their services.
- 8:08Speaker 5: Right.
- 8:08Speaker 7: It's not just about getting the medication, it's about learning
- 8:10Speaker 7: how to take it properly and making sure that the
- 8:12Speaker 7: effect has you intended to have. And so APHA works
- 8:17Speaker 7: with our members first and foremost to direct advocacy, but
- 8:22Speaker 7: also to direct the creation of practice tool the resources,
- 8:26Speaker 7: and of course to direct the way we advocate for
- 8:30Speaker 7: the progression and for the furtherance of specialty pharmacy practice.
- 8:35Speaker 3: Very good. Also APHA's initiative to bring organizations together where
- 8:42Speaker 3: there's these bridges you go from pediatric pharmacy to the
- 8:48Speaker 3: world of general community to geriatrics and then sometime along
- 8:55Speaker 3: the way obviously especially may fit in there. The role
- 8:59Speaker 3: of the pharmacists is expanding. There's going to be a
- 9:01Speaker 3: day where pharmacists will be paid for their clinical knowledge
- 9:06Speaker 3: that it has nothing to do with a dispensing fee.
- 9:09Speaker 3: What's your vision for that environment of the future of pharmacy.
- 9:13Speaker 3: In comparison, there's a big difference between a dispensing opportunity
- 9:20Speaker 3: or dispensing event versus a clinical consult Yeah.
- 9:27Speaker 7: Absolutely, So, first of all, I really appreciate the words
- 9:31Speaker 7: that you're using. Pharmacists will get paid. That is absolutely
- 9:35Speaker 7: power stats. We will work towards having pharmacists be unversed
- 9:39Speaker 7: where there put a clinical like critise away from the
- 9:42Speaker 7: dispensing of the product. APHA's new membership campaign and you
- 9:46Speaker 7: haven't heard about it as many pass one home. I
- 9:49Speaker 7: puty feel that APHA is where the profession comes together.
- 9:54Speaker 7: Because of that, we are very sensitive to the way
- 9:57Speaker 7: practice is evolving and emerging into different setting, different sectors
- 10:01Speaker 7: of the profession. We want to make sure that as
- 10:03Speaker 7: we advocate for providers set us, as we advocate for
- 10:08Speaker 7: you know, PBM reform, that nobody's being left behind, nobody's
- 10:12Speaker 7: being forgotten about. And so we're kind of make advocacy changes,
- 10:17Speaker 7: advocacy wins that are going to benefit all of arbacy.
- 10:21Speaker 7: Now I say that we are also changing our membership
- 10:25Speaker 7: structures at APHA so that everybody can see themselves at APHA,
- 10:31Speaker 7: whether you're working special the hospital community, nuclear pharmacy, anywhere,
- 10:35Speaker 7: federal pharmacy, or programs. We want you at APHA. We
- 10:39Speaker 7: want to hear and we want to hear from you
- 10:42Speaker 7: as you how our advocacy machinery should be affected. And
- 10:48Speaker 7: I think that together, if we did this together, the
- 10:51Speaker 7: profession will advance and we will get to pharmacy, you know,
- 10:56Speaker 7: clinical services reimbursed in together.
- 11:00Speaker 3: APHA twenty twenty five is coming back to Nashville in February,
- 11:06Speaker 3: March March, March twenty twenty five. Everyone listening, make sure
- 11:10Speaker 3: you mark your calendars. What is the day of March.
- 11:14Speaker 3: It's got here, that's all we'll answerry It's.
- 11:18Speaker 7: March twentieth to twenty five, But please do. And we
- 11:21Speaker 7: have a wonderful, wonderful meeting plan. We have you know,
- 11:25Speaker 7: over one hundred hours of CE available to people. We
- 11:28Speaker 7: have phenomenal keynote speakers.
- 11:30Speaker 9: We are going to have very engaging.
- 11:33Speaker 7: Educational sessions and of course APHA annual meeting ish a
- 11:37Speaker 7: profession comes together, a celebrating the profession.
- 11:40Speaker 3: It's the super Bowl pharmacy. I believe it is, absolutely.
- 11:44Speaker 7: And so we're working hard right now to make sure
- 11:47Speaker 7: that this meeting is going to be special, and it's
- 11:50Speaker 7: gonna be special in one very specific. Wait, we're going
- 11:52Speaker 7: to be sunsetting our academy structures. Okay, so the APHA
- 11:57Speaker 7: Academy of Practice Management, Academy of Research and Sciences, they're
- 12:01Speaker 7: going to be funsive along with the what do you
- 12:03Speaker 7: call the special interest groups. So we're going to be
- 12:06Speaker 7: celebrating our history of academies. But we're also going to
- 12:09Speaker 7: be launching our new community structure with twenty three new
- 12:12Speaker 7: exciting communities that are going to make up aph We're
- 12:16Speaker 7: going to make available more opportunities for pharmacists to get
- 12:19Speaker 7: engaged at whatever level they want. Right, you want to
- 12:22Speaker 7: give us a half an hour or a month, we got you.
- 12:26Speaker 7: You want to give us a day a month, we
- 12:28Speaker 7: got YouTube. You decide how you want to interact with us,
- 12:31Speaker 7: we will put you to work and we will advance
- 12:34Speaker 7: the profession together.
- 12:35Speaker 3: That's awesome. Rafi all Science, thank you so much for
- 12:38Speaker 3: being part of the naspa's twenty twenty four post show.
- 12:40Speaker 3: We will see you back in Nashville at APHA twenty
- 12:43Speaker 3: twenty five.
- 12:44Speaker 7: Thanks Todd, and congratulations to NAFP on a wonderful Meetia.
- 12:47Speaker 3: Thank you. With the evolution of specialty pharmacy, we've always
- 12:55Speaker 3: paid attention to technology. We've paid attention to PBM reform.
- 13:00Speaker 3: We're looking at how artificial intelligence is going to affect us.
- 13:07Speaker 3: Certification and education of our specialty pharmacists are part of
- 13:12Speaker 3: the ecosystem. And I have with me read Kalna, who
- 13:17Speaker 3: has helped to guide the Certified Specialty Pharmacy certification through
- 13:23Speaker 3: the NASP, and this is a big part of our future.
- 13:27Speaker 3: Read welcome to the show.
- 13:29Speaker 10: Thank you zon, pleasure to be here.
- 13:31Speaker 3: All right, So talk to us we know as specialty
- 13:35Speaker 3: pharmacy professionals, why this certification is so important in order
- 13:40Speaker 3: to guide levels of quality, information, understanding, and more so
- 13:47Speaker 3: even evolution depending on what's happening in maybe future disease
- 13:50Speaker 3: states or things like that. But talk to us about
- 13:53Speaker 3: the CSP and why it's why it's so important to
- 13:56Speaker 3: our profession.
- 13:58Speaker 10: And I think that's an excellent question.
- 14:00Speaker 11: You mentioned in your introstatement a message around preparation and confidence.
- 14:05Speaker 11: That's exactly what the Certified Specialty Pharmacy cudential provides. If
- 14:09Speaker 11: you think about the FDA's you know.
- 14:12Speaker 3: Thirty million Americans with three thousand.
- 14:14Speaker 11: Rare diseases, you know you may not have the preparation
- 14:17Speaker 11: to understand these unique rare diseases, how to treat them,
- 14:20Speaker 11: how to be a part of the health care ecosystem
- 14:23Speaker 11: with positions. And it might being certified, you might not
- 14:26Speaker 11: just be prepared and what you know now and might
- 14:29Speaker 11: not what you go tomorrow in your own employment area,
- 14:32Speaker 11: but you'll have a broad spectrum awareness and didactic confidence
- 14:36Speaker 11: that you'll be able to help that patient if they
- 14:39Speaker 11: were to arrive on a non routine basis. So preparation
- 14:43Speaker 11: confidence and patient central care is that the CSP can provide.
- 14:48Speaker 3: What has been the feedback from you graduated from the
- 14:53Speaker 3: certification twenty fifteen? What have quarmacists told you in their
- 15:00Speaker 3: role as specialty pharmacists of how the CSP has supported And.
- 15:06Speaker 11: That's a great question too, because there are many certifications
- 15:08Speaker 11: out there.
- 15:09Speaker 10: You can do residencies, you can.
- 15:11Speaker 11: Do private practice, public nonprofit things like that, and you
- 15:14Speaker 11: can enrich yourselves in a variety of educational ways. I
- 15:17Speaker 11: firmly believe there is no replacement for to certify specially pharmacists,
- 15:22Speaker 11: and it.
- 15:22Speaker 10: Only validates what you know now.
- 15:24Speaker 11: It gives you an opportunity to study about the conditions
- 15:27Speaker 11: and patients, so you've not encountered in your specific pharmacy,
- 15:30Speaker 11: so you are very well rounded and get tested on that,
- 15:32Speaker 11: and you can bring that to the marketplace to help patients, providers, payers,
- 15:37Speaker 11: and what happens.
- 15:38Speaker 10: It's patient centric care.
- 15:39Speaker 11: It's patient focused, patient outcomes, improve quality of life. So
- 15:44Speaker 11: I think when I joined a MAATH kind of awareness
- 15:48Speaker 11: of a CSP and I got certified, I was number
- 15:51Speaker 11: one hundred and fifty one, and we noticed more special
- 15:53Speaker 11: pharmacists out there, and we just crossed eighteen hundred in
- 15:56Speaker 11: this past fee.
- 15:56Speaker 10: It's great, and there's more people to help, there's more
- 16:00Speaker 10: thumbs to work with in terms of healthcare.
- 16:01Speaker 11: Providers, players and manufacturers industry. It's an internal validation to
- 16:05Speaker 11: give you that confidence. It's also external validation in the
- 16:09Speaker 11: marketplace that someone on that team has the didactic background to.
- 16:12Speaker 6: Be helpful and be part of a health con team.
- 16:15Speaker 3: One of the parts the mysteries of specialty pharmacy and
- 16:21Speaker 3: dispelling misinformation per se from big, big, big names like
- 16:28Speaker 3: Mark Cuban, who's been wonderful and bringing attention to the
- 16:33Speaker 3: PBM reform and the need for transparency. But several times
- 16:37Speaker 3: publicly he said, oh yeah, when you hear the words
- 16:40Speaker 3: specially pharmacy. It's it's made up. It's just to make
- 16:44Speaker 3: more money. And of course we all listen to him saying,
- 16:47Speaker 3: I love you for the attention that you're bringing our profession.
- 16:50Speaker 3: But come on, you've got to take a look at
- 16:52Speaker 3: what's really different in specialty pharmacy. So there's a business
- 16:57Speaker 3: aspect to specially pharmacy, and there's so many puzzle pieces.
- 17:01Speaker 3: Is the CSP also in the ecosystem of it in
- 17:04Speaker 3: and of itself? Is it talking about the business side
- 17:07Speaker 3: of especially films.
- 17:08Speaker 11: Yeah, so you make a good point of it's just
- 17:11Speaker 11: just another costly thing that is in an afflated healthcare
- 17:15Speaker 11: market in the United States, And I actually believe it's
- 17:17Speaker 11: the opposite because for the price that it takes to
- 17:20Speaker 11: train and get certified, you would save your company and
- 17:23Speaker 11: your patient's tremendous value. It's not just on the exam content.
- 17:27Speaker 11: Sixty five percent is clinical management. There's an intake process.
- 17:30Speaker 11: That intake process around current eleven percent talks about connecting
- 17:34Speaker 11: with the patient, motivational interviewing, understanding your affordability options, their demographics,
- 17:39Speaker 11: and then there's also fulfillment to make sure they actually
- 17:41Speaker 11: get the med We just came from a presentation from
- 17:44Speaker 11: Doug an hour ago that you know, thirty one percent
- 17:46Speaker 11: of prescriptions aren't even filled. You know, six months later,
- 17:49Speaker 11: even though the patient took the time to share honestly
- 17:52Speaker 11: their condition with a prescriber, diagnosis was identified, a treatment
- 17:56Speaker 11: was agreed upon.
- 17:57Speaker 10: It still wasn't filled.
- 17:58Speaker 11: So the CSP everything that covers that intake process to
- 18:02Speaker 11: be a trusted resource for the patient short and long term.
- 18:05Speaker 11: The clinical management in terms of keeping the medication tolerated
- 18:09Speaker 11: at the patient switching to one that will work and
- 18:12Speaker 11: meet the medical diagnostic as well as patient comfort fulfillment,
- 18:17Speaker 11: but also the follow up. So I do think the
- 18:19Speaker 11: CSP touches on a variety of things and if you
- 18:22Speaker 11: do it right the first time, then you're not wasting
- 18:25Speaker 11: going from MEDA to B two C when you knew
- 18:28Speaker 11: betdev is.
- 18:28Speaker 10: The right one all along here.
- 18:30Speaker 3: Yep, thank you so much, doctor Reid calling off for
- 18:33Speaker 3: being part of the NSP's podcast recap and we'd like
- 18:37Speaker 3: to learn more about the Certified Specialty Pharmacy Program and track.
- 18:43Speaker 3: We're going to send all of our listeners to the
- 18:46Speaker 3: NASP's website. We will have a show link in the
- 18:49Speaker 3: show notes for you to click to go right to
- 18:52Speaker 3: the section that NASP supports read.
- 18:54Speaker 11: Thank you, Todd, I thank you for your awareness and
- 18:57Speaker 11: the opportunity.
- 18:57Speaker 10: And I'm welcome to come back every.
- 18:59Speaker 3: Time we are here with returning guests. Doctor Russell Robbins
- 19:07Speaker 3: with Purple Lab. It is so great to be back
- 19:10Speaker 3: at ANASP and seeing you here, Russell. How are you.
- 19:12Speaker 12: I'm doing great, Todd, And it's always great to see
- 19:14Speaker 12: you here. And this has been such a fantastic conference
- 19:16Speaker 12: already and it's only day one.
- 19:18Speaker 3: Absolutely all right. Diane Varon, you are part of the
- 19:22Speaker 3: Purple Lab team. Tell our listeners what you do at
- 19:26Speaker 3: Purple Lab.
- 19:28Speaker 8: Hi, Chad, it's great to see you again and this
- 19:31Speaker 8: is an awesome conference at Purple Lab. I'm a senior
- 19:34Speaker 8: director of Clinical Pharmacy Analytics and I work to support
- 19:42Speaker 8: across the organization sales, marketing, solutions, engineering and product development
- 19:51Speaker 8: to make sure that we are constantly looking across the
- 19:56Speaker 8: data landscape for trending in a pharmacy and healthcare.
- 20:02Speaker 3: All right, So what Purple Lab has done in the
- 20:05Speaker 3: past has been able to bring us how data is
- 20:09Speaker 3: being leveraged in specific instances disease state management. You did
- 20:14Speaker 3: a wonderful episode on obesity. I want to talk about
- 20:19Speaker 3: twenty twenty five in the future and how you're going
- 20:21Speaker 3: to continue to kind of narrow into teaching specially pharmacies
- 20:27Speaker 3: and organizations how to better utilize their data and get
- 20:30Speaker 3: more out of it for patient care. Russ share with
- 20:33Speaker 3: us an example of another project that you've been working
- 20:36Speaker 3: on lately and how this ties into specialty pharmacy.
- 20:39Speaker 12: Sure, no, So we've been working on a few different one, Todd,
- 20:42Speaker 12: One is on looking at biomarkers and biogenomics. Another has
- 20:48Speaker 12: been in a specialty pharma areas around biosimilars, and that's
- 20:53Speaker 12: what we're presenting here at this conference. We've also been
- 20:56Speaker 12: looking at treatment patterns to look to see, you know,
- 21:01Speaker 12: for any given medical condition, when you have an elective
- 21:04Speaker 12: surgery or a non elective surgery, what other conditions and
- 21:10Speaker 12: treatments are related to that, so you can start to
- 21:12Speaker 12: put together a full picture of the individual patient. From
- 21:17Speaker 12: a specialty pharmacide though, we really are looking at areas
- 21:21Speaker 12: and opportunities around either specific drugs to understand who's getting
- 21:26Speaker 12: the medication, who is abandoning the medication when they get
- 21:30Speaker 12: the prescription, what are the main reasons for denials and
- 21:33Speaker 12: rejections of the medication, and so looking at all of
- 21:36Speaker 12: those different components, we can start to identify why certain
- 21:41Speaker 12: barriers exist and then how to overcome them. Whether it's
- 21:45Speaker 12: based on seoh information, whether it's based on plan design,
- 21:50Speaker 12: whether it's based on location of where the person is
- 21:54Speaker 12: trying to fill the prescription.
- 21:57Speaker 3: Diane, I'm a little bit of a futurist of science fiction.
- 22:00Speaker 3: It's one of my most favorite things, Big Star Wars
- 22:03Speaker 3: fan matrix, things like that. There was a movie out
- 22:07Speaker 3: five six years ago from Bradley Cooper where he took
- 22:11Speaker 3: a pill and all of sudden it let him unlock
- 22:15Speaker 3: like one hundred percent of his brain or something like that. Limitless,
- 22:18Speaker 3: Limitless exactly. I love that movie. So I'm still waiting
- 22:22Speaker 3: for them to release that drug. By the way, so
- 22:24Speaker 3: if you guys have any information, I call it the
- 22:28Speaker 3: MZ one or something like that. But anyway, so on
- 22:31Speaker 3: that front of future, I know enough about pharmaco genomics
- 22:36Speaker 3: and biosimilars and being able to when I think of
- 22:38Speaker 3: an accolleage drug drug, or I think of something that
- 22:41Speaker 3: is super expensive, if a physician team pharmacists team could say, hey,
- 22:46Speaker 3: based on this test, we're at least narrowing down for
- 22:49Speaker 3: this specific patient that we know these bolibinem and apps
- 22:53Speaker 3: aren't gonna fit specifically, maybe we moved to some other compound.
- 22:58Speaker 3: Talk to us about how day is going to help
- 23:01Speaker 3: the physician pharmacist teams in the future kind of foresee
- 23:04Speaker 3: some of that and kind of dial into it.
- 23:06Speaker 8: So, yeah, so I totally agree with you. This is
- 23:10Speaker 8: where we need to be where approaching that area. And
- 23:13Speaker 8: it's important because we know that it started very simply
- 23:18Speaker 8: several years ago, maybe ten twenty years ago, thinking about
- 23:22Speaker 8: the fact that people are all different, so giving one
- 23:25Speaker 8: drug does not always affect to patients in the same way,
- 23:30Speaker 8: and more and more testing and developing certain biomarkers. Initially
- 23:36Speaker 8: it was just blood tests, but biomarkers that'd say, hey,
- 23:38Speaker 8: this person's different than the next person. That feeds into
- 23:42Speaker 8: how drugs have become developed. And now we're seeing those
- 23:46Speaker 8: targeted therapies to what you're referring to. So what data
- 23:50Speaker 8: does is that, you know, similar to what we do
- 23:54Speaker 8: it Purple lab like looking across the whole landscape and
- 23:57Speaker 8: bringing that disparate data together, whether it's metal, the drug,
- 24:01Speaker 8: and then what happens with lab testing, molecular biomarket testing
- 24:06Speaker 8: is what they call it, so that you key in
- 24:08Speaker 8: on those differences across people. And it's really just kind
- 24:12Speaker 8: of fitting you know, the round peg into the round
- 24:15Speaker 8: hole versus what could be, you know, the round pig
- 24:18Speaker 8: into the square hole. And this is very important because
- 24:23Speaker 8: you need to have visibility and it also.
- 24:25Speaker 10: Needs to be connected.
- 24:26Speaker 8: So you need to know that Todd is having a
- 24:31Speaker 8: medical test, He's going to his office, he's getting the
- 24:35Speaker 8: testing done. That testing is going to determine what does
- 24:40Speaker 8: his kind of molecular biology look like, so that the
- 24:43Speaker 8: right drug is selected for you know, potentially preventing.
- 24:52Speaker 10: Side effects and toxicities, but.
- 24:54Speaker 8: Also improving your response, which improves the outcome. Improving the outcome,
- 24:59Speaker 8: improves your quality of life and reduces costs. And data
- 25:03Speaker 8: is key in that because if you do not have
- 25:05Speaker 8: visibility across all of those kind of service areas, then
- 25:09Speaker 8: you're not able to really tailor what you're doing to
- 25:14Speaker 8: individual people.
- 25:16Speaker 12: Excellent, and you know I'm to add to that, you know,
- 25:18Speaker 12: I think the other thing that's also happened is I
- 25:21Speaker 12: remember more than ten years ago, they had you know,
- 25:23Speaker 12: the first molecular test to see you know, you'd spit
- 25:27Speaker 12: into a little cup and send it off to a
- 25:29Speaker 12: lab and they would tell you if you could metabolize.
- 25:31Speaker 10: Certain drugs were not.
- 25:33Speaker 12: But quite often by the time you got the results back,
- 25:36Speaker 12: you already knew if you failed the treatment because it
- 25:38Speaker 12: would take so long. So I think one of the
- 25:40Speaker 12: things that we're seeing now is because of the precision medicine,
- 25:46Speaker 12: you know, and the timeliness of some of these things,
- 25:48Speaker 12: you know, we can get the answers faster, so that
- 25:50Speaker 12: way occasions are getting the care in a much more
- 25:53Speaker 12: timely manner.
- 25:55Speaker 3: Doctor Reuss Diane to spend special for us to share
- 25:58Speaker 3: an ASP podcast twenty twenty four. Thank you for your
- 26:01Speaker 3: insights the ecosystem of specialty pharmacy. What better place to
- 26:10Speaker 3: be than the NASP twenty twenty four Here in Nashville.
- 26:14Speaker 3: I'm with Chuck Collins. I want to thank you Chuck
- 26:17Speaker 3: for being part of the show. Yeah, absolutely all right.
- 26:20Speaker 3: Lots of changes happening, not only in specialty, but just
- 26:23Speaker 3: in general and payment. One of our sponsors called Accessia
- 26:27Speaker 3: Health fines funding for patients that have run out of options,
- 26:32Speaker 3: and they're just a saint to the whole mix. You
- 26:36Speaker 3: have some information share with our listeners based on moving
- 26:42Speaker 3: pieces that are taking place right now, something's going to
- 26:45Speaker 3: be changing in January twenty twenty five. Can you give
- 26:48Speaker 3: our listeners an update to what the Reduction Act, the
- 26:52Speaker 3: Inflation Reduction Act?
- 26:53Speaker 9: Yeah, absolutely, the IRA, the Inflation Reduction Act, who's actually
- 26:57Speaker 9: passed in August of twenty twenty two, and now we're
- 27:00Speaker 9: starting to see all the implementation of that. And actually
- 27:03Speaker 9: what's going to happen in January January first of twenty
- 27:06Speaker 9: twenty five is two things, and they're actually major events.
- 27:11Speaker 9: One is the Medicare Part D benefit redesign. So we're
- 27:15Speaker 9: going from a benefit design that's got four stages in
- 27:18Speaker 9: it right now that are actually going to go down
- 27:20Speaker 9: to three. And for the Medicare beneficiary, they only have
- 27:23Speaker 9: two phases, which is going to be an initial deductible
- 27:26Speaker 9: phase if they have one, and an initial coverage phase.
- 27:30Speaker 9: And the key thing, Todd, what happens here is that
- 27:34Speaker 9: it's for the very first time Medicare Part D beneficiaries
- 27:37Speaker 9: are going to be capped at two thousand dollars. So
- 27:41Speaker 9: the very patient financial assistance you were just talking about
- 27:45Speaker 9: from a carrier Health is actually going to only have
- 27:48Speaker 9: to be two thousand dollars per beneficiary because they now
- 27:52Speaker 9: have a cap for the very first time. So that's
- 27:54Speaker 9: huge when you think about the benefit design. If I
- 27:58Speaker 9: take a drug that's thirteen thousand dollars month in twenty
- 28:00Speaker 9: twenty three, that beneficiary would have paid out of pocket
- 28:04Speaker 9: ten thousand, one hundred and thirty five dollars, right, And
- 28:07Speaker 9: in twenty twenty four, the year we're in now, the
- 28:10Speaker 9: catastrophic phase has been eliminated. And by doing that, the
- 28:14Speaker 9: most that a beneficiary what pays around thirty one fifty
- 28:17Speaker 9: to thirty two to fifty in that range, Now as
- 28:20Speaker 9: we go into twenty twenty five, it's only going to
- 28:22Speaker 9: be two thousand dollars. So that's great news, right for
- 28:25Speaker 9: the very first sign group, we've capped this for them. Now,
- 28:28Speaker 9: two thousand dollars is a lot of money, yeah, right,
- 28:31Speaker 9: and especially if you are retired on a fixed income.
- 28:35Speaker 9: So the other part of the Inflation Reduction Act that
- 28:38Speaker 9: takes place is this new payment option. It's called the
- 28:41Speaker 9: Medicare Prescription Payment Plan or MPPP, and what it does,
- 28:47Speaker 9: you'll hear the term called smoothing you're able to Let's
- 28:51Speaker 9: say this happens in January and that thirteen thousand dollars
- 28:54Speaker 9: month example, in January, you would hit or you would
- 28:57Speaker 9: owe two thousand dollars in January, and you may say,
- 29:00Speaker 9: I don't have that, where the government, through the Inflation
- 29:04Speaker 9: Reduction Act, has set up a payment program that you
- 29:07Speaker 9: can actually work through your health plan and you can
- 29:09Speaker 9: smooth your payments for all twelve months of the year.
- 29:12Speaker 9: You are not taken away from the responsibility still the
- 29:16Speaker 9: two thousand, but your monthly amount would be reduced. And
- 29:21Speaker 9: that's really what this is all about. So really, time
- 29:24Speaker 9: is on your side. If you start in January and
- 29:26Speaker 9: you have a high cost drug, if you're able to
- 29:28Speaker 9: do that and other nonprofit organizations with grants maybe be
- 29:34Speaker 9: able to pay that two thousand, and you don't even
- 29:36Speaker 9: have to sign up for the program. But the Medicare
- 29:38Speaker 9: procription payment program is completely voluntary. As a matter of fact,
- 29:42Speaker 9: next week when we get into open enrollment. As open
- 29:45Speaker 9: enrollment starts, they're also going to have that option to
- 29:48Speaker 9: sign up for this new payment plan so that they
- 29:50Speaker 9: don't miss anything starting in January or get stuck with
- 29:53Speaker 9: a two thousand dollars bill. They'll be able to smooth
- 29:56Speaker 9: it over over time and you can in anytime. You
- 30:00Speaker 9: can opt out anytime you want. It's completely voluntary. Instead
- 30:04Speaker 9: of paying anything at the point of service at the
- 30:06Speaker 9: specialty pharmacy or at a retail pharmacy, the bill will
- 30:11Speaker 9: come from your health plan. So the health plan takes
- 30:13Speaker 9: on that onus and they actually have to calculate the
- 30:16Speaker 9: numbers and give you a bill a month later, like
- 30:19Speaker 9: here's what you will. And so it's a great program
- 30:22Speaker 9: that's sitting out there to help people that you may
- 30:24Speaker 9: not have two thousand dollars or even five hundred dollars
- 30:27Speaker 9: for wherever.
- 30:28Speaker 3: It need to go.
- 30:29Speaker 9: And so I think it's going to be interesting as.
- 30:31Speaker 4: It takes place.
- 30:32Speaker 9: Is a lot going on. And the government also set
- 30:35Speaker 9: up through CMS that a health plan has to notify pharmacies,
- 30:39Speaker 9: specialty pharmacies that this person may be eligible with this program.
- 30:43Speaker 9: And they're using a marker, if you will, of six
- 30:48Speaker 9: hundred dollars. So if you have a prescription that six
- 30:50Speaker 9: hundred dollars or more month, this person might likely that's
- 30:54Speaker 9: so termly using might likely be able to benefit from
- 30:57Speaker 9: this program if it's less than that they may not
- 31:00Speaker 9: likely be able to benefit from the program. So it
- 31:03Speaker 9: really is just another way to help, you know, lower
- 31:05Speaker 9: the cost on a monthly basis, so the seniors, you know,
- 31:09Speaker 9: those over sixty five and medicare are able to afford
- 31:12Speaker 9: the medicine.
- 31:14Speaker 3: It's excellent, excellent. I appreciate this information, Chuck Collins. We're
- 31:19Speaker 3: here at the NSP podcast twenty twenty four coverage. We're
- 31:23Speaker 3: excited that you're bringing us this kind of intelligence. If
- 31:27Speaker 3: there's someone listening and wants to kind of reach out
- 31:30Speaker 3: to you and engage ask more questions, what's the best
- 31:32Speaker 3: way to reach you.
- 31:33Speaker 9: Sure, My website or I should say, my email is
- 31:38Speaker 9: dot Collins at the EJS excuse me, the hssroom dot.
- 31:43Speaker 3: Com, THEHSS group dot com. Very good, Chuck, thank you
- 31:47Speaker 3: so much. You are listening to the NASP podcast part
- 31:55Speaker 3: of the Pharmacy Podcast Network. I have a special story.
- 31:59Speaker 3: Real quick, we're going to take kind of a slow
- 32:01Speaker 3: down break from the NSP podcast. It's amazing. Well two
- 32:06Speaker 3: parts of the story. First part, I think this makes
- 32:08Speaker 3: me feel old, but the real the purity of this
- 32:12Speaker 3: story is I met Courtney Smith, doctor Courtney Smith, who's
- 32:16Speaker 3: actually one of our Pharmacy Fifty Alumni of the fifty
- 32:19Speaker 3: most influential people in our pharmacy profession. Courtney, you and
- 32:23Speaker 3: I met when you were a P two and you
- 32:27Speaker 3: volunteered for Pharmacy Future Leaders, which was one of our
- 32:30Speaker 3: podcasts that was really dedicated to understanding what our pharmacy
- 32:35Speaker 3: students thought of of the future of pharmacy. And here
- 32:37Speaker 3: you're standing at the NSP's booth and you're so deeply
- 32:41Speaker 3: involved now, not only in this association, but really you
- 32:45Speaker 3: forged your own path and what you wanted to do
- 32:48Speaker 3: in pharmacy and how far you've come. I'm so proud
- 32:51Speaker 3: of you.
- 32:52Speaker 13: Thank you so much, Todd. It's a pleasure to be
- 32:54Speaker 13: here this week, and it really has been quite the journey.
- 33:00Speaker 13: I've definitely taken the path a little less traveled. Back
- 33:05Speaker 13: when I was a student, I had talked to you
- 33:07Speaker 13: about some of the roles that pharmacists could do looking
- 33:10Speaker 13: at provider status, and I thought one day I'd be
- 33:14Speaker 13: able to manage patient's medications without even being on the
- 33:17Speaker 13: bench and contribute alongside the provider. And I'm so happy
- 33:21Speaker 13: I'm able to do that. In the Rheumatology Specialty.
- 33:23Speaker 3: Services it's great. What's your shout out to some of
- 33:27Speaker 3: our P two's and P three's. P four is listening
- 33:30Speaker 3: right now. Who do want to go into a different
- 33:33Speaker 3: facet of pharmacy. Maybe they don't want to go the
- 33:36Speaker 3: hospital system track, maybe they don't want to go retail independent,
- 33:39Speaker 3: Maybe they want to go a specialty disease state. What
- 33:43Speaker 3: do you say to those young pharmacists.
- 33:45Speaker 10: I always say, hang on to those ideas.
- 33:48Speaker 13: So if you have something stuck in your head for
- 33:51Speaker 13: more than a few minutes, it's probably worthwhile to keep
- 33:54Speaker 13: tapping back into it, and you may gather pieces along
- 33:57Speaker 13: the way of a traditional route to do something more
- 34:00Speaker 13: non traditional.
- 34:01Speaker 3: All right, your advocacy for our profession has been incredible.
- 34:05Speaker 3: You work with the PPA over the years, the Pennsylvania
- 34:08Speaker 3: Pharmacists Association. How are you working with NSP.
- 34:12Speaker 13: Yeah, so I'm actually taking a look today at their committee, Bear.
- 34:17Speaker 13: I have thoughts of maybe looking more towards looking into
- 34:22Speaker 13: their technologies committee or the clinical education committees right now.
- 34:27Speaker 13: Last year I was able to volunteer as a subject
- 34:30Speaker 13: matter expert on the CSP review Board for the tests.
- 34:35Speaker 13: I'm a CSP test member as well, so I think
- 34:39Speaker 13: that's been very helpful preparing me to cross train in
- 34:43Speaker 13: all types of disease states, including rheumatology. So I would
- 34:46Speaker 13: highly recommend that. And that's all, you know, something you
- 34:49Speaker 13: can look into here at NASS today.
- 34:51Speaker 3: So did you go through the CSP yourself right? Yes?
- 34:55Speaker 13: And I did the review course here in Orlando three
- 34:59Speaker 13: years go and then took the exam.
- 35:02Speaker 3: Room with tard arthritis pain management. How has the CSP
- 35:08Speaker 3: helped you to kind of dig down into that as
- 35:12Speaker 3: a specialty pharmacist.
- 35:14Speaker 13: Yeah, I think that every specialty pharmacy has a lot
- 35:18Speaker 13: of depending on what region you're in and what access
- 35:20Speaker 13: to medications you have in your pharmacy itself. It helps
- 35:24Speaker 13: you broaden your scope of practice and knowledge base towards
- 35:27Speaker 13: all different types of specialtyments available, maybe not only just
- 35:31Speaker 13: the ones that you feel for. So I find that
- 35:33Speaker 13: that's really helpful keeping me up to date with all
- 35:36Speaker 13: that's out there.
- 35:38Speaker 3: Courtney, you love watching your career grow and being a
- 35:42Speaker 3: super small part of it and just helping to amplify
- 35:44Speaker 3: your voice. Always love talking with you on the Pharmacy
- 35:48Speaker 3: Podcast Network and thank you for being here at the
- 35:50Speaker 3: NSP podcast.
- 35:51Speaker 13: Thank you so much. Todd.
- 35:56Speaker 3: Are there any epithy theologists in the house calling, paging
- 36:00Speaker 3: epidemiologist in the house, please pick up the redbone press
- 36:05Speaker 3: number three.
- 36:07Speaker 14: Oh yeah, I think there's one here.
- 36:09Speaker 3: We have doctor Elson, Jacob farm D. Hey, it's so
- 36:15Speaker 3: nice to meet you here at NASP twenty twenty four.
- 36:18Speaker 3: And I like epidemiology because here are two reasons. Not
- 36:22Speaker 3: for real, I'm actually lying. My sister is a nutritionist,
- 36:28Speaker 3: a dietitian, and she started into her DOO position where
- 36:33Speaker 3: she wants to be a physician assistant and her most
- 36:37Speaker 3: challenging course ever in her life is epidemiology. And when
- 36:41Speaker 3: she said that, it brought attention to it because she's
- 36:44Speaker 3: ten times smarter than I am. And I'm like, what
- 36:47Speaker 3: is it about epidemiology that's so scary? And I'm like, well,
- 36:51Speaker 3: now we have you here, maybe we can get an
- 36:53Speaker 3: answer to that question.
- 36:56Speaker 14: I like the way that you frame that.
- 36:59Speaker 4: I mean, I think it's.
- 37:00Speaker 14: A lot of mathematical concepts involved when you're calculating and
- 37:05Speaker 14: appreciating the numbers, and that can be scary for some
- 37:08Speaker 14: folks initially, but I think ultimately it's how do you
- 37:12Speaker 14: appreciate the numbers to tell a story? And then use
- 37:16Speaker 14: that story to guide you in how you can impact
- 37:19Speaker 14: patient care. So I think for some folks, you know,
- 37:22Speaker 14: when you first take a look and you're seeing that data,
- 37:25Speaker 14: it's a little bit jarring, you know, like what do
- 37:27Speaker 14: you do with this? But once you sort of understand
- 37:30Speaker 14: how to work with it, how do you, you know, use
- 37:33Speaker 14: and leverage your skill set to tell that story in
- 37:36Speaker 14: a clear way?
- 37:38Speaker 3: It's powerful.
- 37:39Speaker 14: Data is powerful, but how do you leverage that to
- 37:41Speaker 14: actually advance patient care? So I think that might be
- 37:46Speaker 14: part of that.
- 37:48Speaker 3: Doctor Jacobs, like, talk to me about the future of
- 37:51Speaker 3: data analytics and the farm dy and those pharmacists who
- 37:56Speaker 3: might say, listen, I don't want to be in the
- 38:00Speaker 3: community setting. I don't want to be in the hospital setting.
- 38:03Speaker 3: I want to go deep into research. I want to
- 38:06Speaker 3: go deep into analytics and data. Talk to me and
- 38:09Speaker 3: those pharmacists that are listening to us right now who
- 38:12Speaker 3: are fascinated by that.
- 38:13Speaker 14: Yeah, I think it's great if people have an interest
- 38:17Speaker 14: in data and analytics. I think that there's only going
- 38:21Speaker 14: to be more and more ability to work with data.
- 38:25Speaker 14: I mean, now we have AI that's like here and
- 38:28Speaker 14: here to stay, and I think it's going to allow
- 38:30Speaker 14: us to do so much more. I think it's good
- 38:34Speaker 14: because it helps us to answer a lot of questions.
- 38:36Speaker 14: It helps us to frame things better, It helps us
- 38:40Speaker 14: to ask questions better, it helps us to answer this question.
- 38:44Speaker 14: So it's really finding out what are you passionate about?
- 38:47Speaker 14: So when we think about data, it's really how do
- 38:49Speaker 14: we ask appropriate questions and then frame things in a
- 38:53Speaker 14: way that can allow us to take the next steps. So,
- 38:56Speaker 14: for example, in my role now, I'm a director of
- 38:59Speaker 14: Outcomes and Analytics with an Inflammation and Immunology advisor, and
- 39:04Speaker 14: I work with folks across the Northeast health systems idms,
- 39:07Speaker 14: specialty pharmacies to think about how to leverage data to
- 39:13Speaker 14: ask questions and identify gaps in care that might be present,
- 39:17Speaker 14: and then find solutions. Usually the folks are working within
- 39:21Speaker 14: their own systems to find those solutions and close those
- 39:24Speaker 14: care gaps, so we're able to advance patient care and
- 39:28Speaker 14: patients have better outcomes because of that. So it's really
- 39:31Speaker 14: thinking about, you know, what is it that I can
- 39:34Speaker 14: bring as a pharmacist, as a clinician, as an alemiologist.
- 39:40Speaker 4: To advance that patient care.
- 39:41Speaker 14: And I think pharmacists come with a unique skill set,
- 39:44Speaker 14: a way of thinking which can allow for so much
- 39:48Speaker 14: more than what we even think we can do. So
- 39:51Speaker 14: it's really you know, tapping into that, tapping into that expertise,
- 39:55Speaker 14: tapping into that ability to critically think, and also coming
- 39:59Speaker 14: up with creative solutions that we have that unique perspective
- 40:03Speaker 14: to bring in advanced patient care in a different way.
- 40:06Speaker 14: So yeah, that's that's why I really enjoy and love
- 40:11Speaker 14: thinking about problems in healthcare and and you know a
- 40:15Speaker 14: lot of sort of things that people think conceptually, but
- 40:18Speaker 14: health equity, social determinants of health. What are those those
- 40:22Speaker 14: barriers that patients experience and how can we close those
- 40:26Speaker 14: those barriers? How can we close those gaps in a
- 40:28Speaker 14: meaningful way in a way that we can actually see
- 40:31Speaker 14: the change, the positive change that patients.
- 40:33Speaker 3: Can experience, Doctor Jacob, Doctor Jacob, why do you like
- 40:37Speaker 3: being part of the NESP?
- 40:40Speaker 14: The NSP, I think is an opportunity to meet folks
- 40:43Speaker 14: who have that patient centric mindset. It's my first time
- 40:47Speaker 14: actually attending the NSP and m am experiencing you know,
- 40:51Speaker 14: such a warmth here. People want to talk to you,
- 40:55Speaker 14: They want to, you know, learn what you're you're doing,
- 40:59Speaker 14: and you know what it is that they can contribute
- 41:02Speaker 14: in different ways. How can you meet people who think
- 41:05Speaker 14: differently or alike? So I think it's it's really a
- 41:08Speaker 14: great conference, I think for folks who think within specialty
- 41:11Speaker 14: pharmacy or in any way related. I mean, I've had
- 41:15Speaker 14: a really wonderful time here just meeting folks and connecting.
- 41:19Speaker 3: We appreciate you being part of the NSP post show.
- 41:22Speaker 3: We want to stay in touch with you for like LinkedIn.
- 41:25Speaker 3: If someone wants to reach out to you because they're
- 41:27Speaker 3: curious about how to work with you and Advisor, what's the
- 41:29Speaker 3: best way to reach out to you?
- 41:31Speaker 6: So email?
- 41:33Speaker 14: So my email is Elson E l SPN dot Jacob
- 41:36Speaker 14: Jacob Advisor dot com. And I'm also on LinkedIn, so
- 41:40Speaker 14: you can just look me up Elson Jacob and yeah,
- 41:44Speaker 14: those are good ways to reach out.
- 41:45Speaker 3: Excellent. Yeah, thank you for being part of the show.
- 41:47Speaker 8: Thank you.
- 41:53Speaker 3: A major staple player, somebody who has partnered with the
- 41:56Speaker 3: pharmacy profession for years was known as a MARES source.
- 42:00Speaker 3: Bergen has restructured and rebranded to Sincora and I get
- 42:05Speaker 3: an opportunity to talk with Steven from Secora and introduce
- 42:08Speaker 3: yourself Steveen and tell us what's happening at Secora?
- 42:12Speaker 15: Yeah, hi everyone, Stephen Garso from Sincora, Senior Director of
- 42:17Speaker 15: Pair Strategy with Sancor.
- 42:19Speaker 6: You know, the core, we are a.
- 42:21Speaker 15: Pharmacy distributor, but we have a suite of solutions that
- 42:26Speaker 15: we use to help our customers navigate the space, you know,
- 42:30Speaker 15: service anything that they're needing help with.
- 42:33Speaker 6: And you know, we're much more now than just a distributor.
- 42:37Speaker 15: So the solution that I work for is the Accelerate
- 42:40Speaker 15: Specialty PSAO, and our goal is to help these specialty
- 42:44Speaker 15: pharmacies that are in our network gain access to specialty
- 42:47Speaker 15: networks within payers that maybe they wouldn't have access to
- 42:51Speaker 15: on their own.
- 42:52Speaker 3: So we're talking about health system pharmacies, we're talking about
- 42:57Speaker 3: long term care specialty community. What other sector of pharmacy
- 43:03Speaker 3: is soncora in.
- 43:05Speaker 15: Yeah, so within our PSAO, we actually have three different
- 43:09Speaker 15: types of pharmacies health system specialty pharmacies, independent specialty pharmacies
- 43:14Speaker 15: that are standing on.
- 43:16Speaker 6: Their own, not owned by any payer.
- 43:18Speaker 15: Along with medically integrated dispensers which you can think of
- 43:21Speaker 15: as you or large oncology practices that have dispensing capabilities.
- 43:26Speaker 15: All of the pharmacies in our network are accredited specialist
- 43:28Speaker 15: in pharmacies, so it's a big plus for payers.
- 43:31Speaker 6: When we're negotiating with them.
- 43:33Speaker 15: And on top of that, you know, we really try
- 43:37Speaker 15: to help these specialty pharmacies gain access because you know,
- 43:41Speaker 15: they do provide a very high level of care that.
- 43:44Speaker 6: Members may not be receiving elsewhere.
- 43:46Speaker 15: So that's the value that we bring when we're talking
- 43:49Speaker 15: to pairs is listen, you know our member satisfaction scores
- 43:52Speaker 15: are through the roof. We can help with that cost
- 43:57Speaker 15: savings of value for the payers and you know they
- 44:01Speaker 15: get access to over one hundred and thirty specialty pharmacies
- 44:04Speaker 15: by doing one contract with us.
- 44:05Speaker 3: It's great. I would also think having an advantage as
- 44:09Speaker 3: a major wholesaler who has that kind of pedigree and
- 44:13Speaker 3: reputation history that a manufacturer is going to come to
- 44:17Speaker 3: you to almost assess which specially pharmacies they should be
- 44:21Speaker 3: involved with.
- 44:22Speaker 15: Yes, I would imagine that is the case. You know,
- 44:26Speaker 15: with our manufacturer and IR team, you know, we do
- 44:28Speaker 15: have a very strong presence in the manufacturing space for that,
- 44:33Speaker 15: you know that industry relations, So that is a benefit
- 44:38Speaker 15: with the specialty pharmacies.
- 44:40Speaker 6: In our network. You know they're all.
- 44:42Speaker 15: Health system independent, medically integrated with spensers that stand on
- 44:46Speaker 15: their own.
- 44:47Speaker 6: We don't have any sort of structure within that pharmacy.
- 44:53Speaker 6: They manage it on their own. We just help them
- 44:56Speaker 6: with those pair contracts and we provide you know, if
- 44:59Speaker 6: a manufacturer.
- 44:59Speaker 15: Is interested in some of our pharmacies in the network,
- 45:01Speaker 15: we definitely can connect them.
- 45:03Speaker 6: With those pharmacies to have those conversations.
- 45:06Speaker 3: Steven, we really appreciate your support with the NASP being
- 45:10Speaker 3: a sponsor here and also participating in the NSP podcast.
- 45:13Speaker 3: Thank you, No, this is great.
- 45:14Speaker 16: Thank you.
- 45:20Speaker 3: Hey, and we are here with Andrew Bab with Biotech Remedies. Andrew,
- 45:25Speaker 3: welcome to the show.
- 45:27Speaker 6: Thanks for having me today.
- 45:28Speaker 3: I appreciate it all right. So when I think of
- 45:32Speaker 3: specialty pharmacy, how complicated that it can be number one
- 45:35Speaker 3: to get in Number two to document the correct things
- 45:38Speaker 3: that manufacturers are asking for, whether that's REMS reporting or
- 45:42Speaker 3: data or follow up. That's great. And I'm a technologist.
- 45:47Speaker 3: I love thinking to the workflow and the technology. Want
- 45:49Speaker 3: to respect is the patient themselves of how do we
- 45:53Speaker 3: make pivots and adjustments to making specialty pharmacy better? Something
- 45:58Speaker 3: that you guys are doing in your championing is digging
- 46:01Speaker 3: down into that data to tell us how do our
- 46:03Speaker 3: patients feel about the types of services that they're getting
- 46:06Speaker 3: from specialty pharmacy. Share with us what you guys have
- 46:09Speaker 3: been working.
- 46:10Speaker 17: On absolutely, So, I mean, the patients are going to
- 46:13Speaker 17: tell you everything that you ever need to know, right
- 46:14Speaker 17: and they are most important. They're the most important thing
- 46:18Speaker 17: to us at biotechs and the most important thing to
- 46:20Speaker 17: us and special until your pharmacy at large. They're are customers.
- 46:24Speaker 17: We are in service of them, so we need to
- 46:26Speaker 17: know if what we're doing is making them happy, is
- 46:28Speaker 17: it making their lives better? Is it improving the outcomes
- 46:32Speaker 17: that they're looking towards? And gathering that information is critical.
- 46:36Speaker 17: So as an a member of an ASP, you know,
- 46:38Speaker 17: we refine the way that we collect patient satisfaction data.
- 46:42Speaker 17: Thanks to the Celliban, the well and company that provides
- 46:45Speaker 17: this satisfaction surveys changed it from a manual process to
- 46:49Speaker 17: an automated process, receiving so much more feedback than we
- 46:52Speaker 17: ever did. The response rate is tremendous comparative to most
- 46:56Speaker 17: survey companies, given us a massive amount of death to
- 47:00Speaker 17: look at. You know, all the satisfaction data, what are
- 47:03Speaker 17: our weak spots, what can we improve upon? And we've
- 47:06Speaker 17: been utilizing that now for the last couple of years,
- 47:08Speaker 17: you know, myself and my other clinical team. We pour
- 47:11Speaker 17: over that data every time it comes in every quarter.
- 47:14Speaker 17: We're looking at success stories, we're looking at challenges, we're
- 47:17Speaker 17: looking at ways that we can improve our processes and
- 47:20Speaker 17: just honing in on those things and having a better
- 47:22Speaker 17: you know, line of sight to them at all times.
- 47:25Speaker 3: So I when I'm listening to you, I'm thinking of
- 47:28Speaker 3: things like data that will tell us how fast does
- 47:31Speaker 3: it take to get the prescription filled after the physician prescribes.
- 47:36Speaker 3: I think of things like how fast is the prescription
- 47:39Speaker 3: getting to the patient, especially if it's traveling through a
- 47:43Speaker 3: mail system of some sort or delivery system. What stands out?
- 47:47Speaker 3: What's kind of the factors really like jumped out at
- 47:50Speaker 3: you from a data perspective that you'd would like to
- 47:52Speaker 3: talk about. From biotech's perspective.
- 47:55Speaker 17: I think the biggest thing that it told us, which
- 47:58Speaker 17: I guess wasn't a surprise, but it was comforting to
- 48:00Speaker 17: see in the data, was how much communication alone can
- 48:04Speaker 17: change the entire outcome for a patient. You know, just
- 48:07Speaker 17: the ability to effectively communicate. You know, we're throwing a
- 48:10Speaker 17: lot of information at new people, right they're dealing with
- 48:13Speaker 17: maybe they're dealing with a new disease, a new concept
- 48:18Speaker 17: that they're not going to have to live with for
- 48:19Speaker 17: the rest of their lives, and it's scary, and they're
- 48:22Speaker 17: getting hit with a lot of information. The physicians hitting
- 48:24Speaker 17: with a lot of stuff. The pharmacy is hitten with
- 48:25Speaker 17: a lot of stuff. It's clinical, it's financial. They are
- 48:29Speaker 17: just having to absorb so much information. And your ability
- 48:32Speaker 17: to just communicate with that, with that, that with them
- 48:35Speaker 17: in an effective way, hold you know, walk them through
- 48:37Speaker 17: each step of the process, make sure that they understand
- 48:40Speaker 17: what's happening and what we can do to improve upon that,
- 48:43Speaker 17: and shepherd them through this process.
- 48:46Speaker 6: That alone will.
- 48:47Speaker 17: Change the entire dynamic of how they feel at the
- 48:49Speaker 17: back end, you know, will will the outcome always be
- 48:52Speaker 17: the same, No, but at least the process is the same,
- 48:55Speaker 17: and you can always marry yourself to that process and
- 48:58Speaker 17: at the end of the day, that will That will
- 49:00Speaker 17: help everybody have a deeper understanding of what's going on,
- 49:03Speaker 17: where we're going, and how we can improve just by
- 49:05Speaker 17: communicating and that was eye opening to singer Andrew.
- 49:09Speaker 3: Thank you so much for being part of the nfp's
- 49:11Speaker 3: podcast coverage of the twenty twenty four event. We're we
- 49:14Speaker 3: going to see you in Denver next year.
- 49:16Speaker 17: I would love to go to Denver. This is my
- 49:18Speaker 17: second year I went into Dallas. Last year was a
- 49:21Speaker 17: great time. Shila and her crew were doing an amazing job.
- 49:24Speaker 17: Every year it's getting bigger and better and more exciting.
- 49:27Speaker 17: So I would love to be in Denver.
- 49:32Speaker 3: What an amazing time we had, Sheila. This has been
- 49:35Speaker 3: so special. This is our fourth time that we've partnered
- 49:38Speaker 3: with you as your press and media partner. I'm proud
- 49:41Speaker 3: of what you've built, what you and the team have
- 49:42Speaker 3: brought together. Thanks so much, tod Yes.
- 49:45Speaker 16: This year, the response to the meeting was incredible, totally.
- 49:49Speaker 16: Everything was record breaking, right a number, a record breaking
- 49:52Speaker 16: number of exhibitors and sponsors, posters on display, attendees, over
- 49:57Speaker 16: nineteen hundred registered attendees, and the participant from our members,
- 50:01Speaker 16: you know, the committees in the workshops and all of
- 50:04Speaker 16: the educational sessions, people that volunteered to peer review an
- 50:07Speaker 16: educational session or judge a poster. I mean, it's just
- 50:10Speaker 16: been incredible that everybody is so willing to come together
- 50:13Speaker 16: to make the show possible.
- 50:15Speaker 3: I've heard from so many people who are excited about
- 50:17Speaker 3: different components of what's coming out of ANASP. Something that
- 50:21Speaker 3: is special is the certification and how that's grown. I
- 50:25Speaker 3: talked with doctor Archchek and his passion for the c SP.
- 50:32Speaker 3: I always get the acronyms mixed up. Talk to us
- 50:34Speaker 3: about the importance of having a certification that's very dialed
- 50:39Speaker 3: into specialty pharmacy.
- 50:41Speaker 16: Absolutely, as we continue to struggle to define rite specialty
- 50:44Speaker 16: pharmacy specialty drug we have this incredible group of pharmacists
- 50:49Speaker 16: who are dedicated to the practice of specialty pharmacy as
- 50:51Speaker 16: it continues to evolve. Right, it's so much different than
- 50:54Speaker 16: when I started in specialty back in the early two thousands.
- 50:57Speaker 16: So having a credential that demonstrates these folks not only
- 51:01Speaker 16: their commitment, but they have the knowledge, They have the experience,
- 51:04Speaker 16: the expertise to effectively manage a specialty patient on a
- 51:08Speaker 16: specialty drug. Whatever it is, right, they understand and they're
- 51:12Speaker 16: able to help that patient on that journey.
- 51:14Speaker 10: Right.
- 51:15Speaker 16: So, I think it's very very important to differentiate these
- 51:17Speaker 16: group of professionals that Hey, you know what, we are
- 51:20Speaker 16: the experts here and we can manage, especially especially pharmacy
- 51:24Speaker 16: patient effectively. They're going to get the best outcome. It's
- 51:27Speaker 16: going to be a cost effective outcome, right to.
- 51:29Speaker 3: Do for all of us. Yes, I'm glad you're mentioning outcomes.
- 51:32Speaker 3: There was a tremendous amount of effort, time and money
- 51:37Speaker 3: put into the NASP survey that just came out that
- 51:41Speaker 3: was all about patient feedback and how patients are feeling.
- 51:44Speaker 3: That is gold. So I want to shout out to listeners.
- 51:48Speaker 3: If you don't know about this, I need you to
- 51:50Speaker 3: reach out to the NSP, reach out to their team.
- 51:52Speaker 3: We'll have a link in the show notes to get
- 51:54Speaker 3: your hands on that report. But share with us a
- 51:57Speaker 3: little bit of the highlights of what you want went
- 52:00Speaker 3: through as an organization to gather that data.
- 52:02Speaker 16: Sure, so, ANASP partners with the Sullivan the well In
- 52:04Speaker 16: Group to administer a patient satisfaction survey. We also have
- 52:08Speaker 16: provider surveys and manufacturer surveys, but and our corporate members
- 52:12Speaker 16: are eligible to participate in the survey. For some of them,
- 52:15Speaker 16: it's complementary, but it's with the hope of you know,
- 52:19Speaker 16: looking at the best practices, looking at what folks are doing.
- 52:22Speaker 16: Are patients satisfied with that?
- 52:23Speaker 3: How do we get better?
- 52:24Speaker 16: Trying to elevate, you know, elevate each other and encourage
- 52:26Speaker 16: each other to get better, and then publishing that information
- 52:30Speaker 16: and you know, shout outs to people who are doing
- 52:31Speaker 16: things that are innovative and unique in enhancing again that journey.
- 52:35Speaker 16: These patients are dealing with so much, right, specialty patients.
- 52:39Speaker 16: Oftentimes it's the first time for some of these people
- 52:41Speaker 16: to be diagnosed. Think, you know, you're get you get
- 52:43Speaker 16: a cancer diagnosis? Oh my god, what do I do?
- 52:46Speaker 7: Right?
- 52:46Speaker 16: An income specialty pharmacy, And so they're so focused not
- 52:49Speaker 16: only on the clinicals right in on you know, making
- 52:52Speaker 16: sure that patients get the medication on time and their
- 52:54Speaker 16: compliant and adherent, but everything else around there, right, the financials,
- 52:57Speaker 16: what else is going on with this patient?
- 52:59Speaker 4: You know that we need to.
- 53:00Speaker 16: Help to address and so satisfaction is so important and
- 53:03Speaker 16: that patient feedback is so important that helps us to
- 53:06Speaker 16: get better.
- 53:07Speaker 3: Never had an opportunity to explore Nashville. This is the
- 53:11Speaker 3: first time I was able to go downtown twice. The
- 53:14Speaker 3: nash Bash was just incredible. You really picked a very
- 53:18Speaker 3: special venue in an atmosphere. There has been so much
- 53:22Speaker 3: collaboration and positivity at this I think this is the
- 53:25Speaker 3: best NASP ever.
- 53:27Speaker 16: Oh my gosh, well, thank you. The nash Bash I
- 53:29Speaker 16: thought was a whole bunch of fun, right, I was
- 53:30Speaker 16: telling people four floors of fun because just like our
- 53:33Speaker 16: membership is so diverse, right, and specialty continues to evolve,
- 53:36Speaker 16: it's so diverse. So I had four, you know, different floors,
- 53:39Speaker 16: you know, and activities on different floors, and it just
- 53:41Speaker 16: was so great to have people come together in a
- 53:43Speaker 16: more social setting.
- 53:44Speaker 14: Right.
- 53:44Speaker 16: We're still talking business, right, and they're still making connections,
- 53:47Speaker 16: but it's nice for them to kind of unwind at
- 53:48Speaker 16: the end of the conference and just have some fun
- 53:51Speaker 16: and to your point, experience all that Nashville has offered.
- 53:54Speaker 16: This is an incredible town, and we've been so great
- 53:56Speaker 16: to kind of take it over for a little bit
- 53:57Speaker 16: of time.
- 53:58Speaker 3: Yes, all right, n ASP twenty twenty five. I'm already
- 54:03Speaker 3: excited about it. A mile high. We're going to Denver
- 54:07Speaker 3: give us a little bit of a shout out and
- 54:10Speaker 3: getting everybody excited for that.
- 54:11Speaker 16: Absolutely, So we are going to try to even you know,
- 54:14Speaker 16: we've raised the bar I think this year we're going
- 54:16Speaker 16: to try to continue to do that. In two weeks,
- 54:19Speaker 16: I head out to Denver to start planning. Some folks
- 54:22Speaker 16: had come up to me and said, hey, I'm from Denver,
- 54:24Speaker 16: so they gave me some ideas about some things to consider.
- 54:26Speaker 16: I'm always looking for that feedback. But again, we want
- 54:29Speaker 16: to make sure that when people visit a new city
- 54:32Speaker 16: where you know, our members live and they practice and
- 54:35Speaker 16: their patients live, that they.
- 54:36Speaker 6: Learn a little bit about where they are.
- 54:38Speaker 8: Right.
- 54:38Speaker 16: Not only you know, we'll continue with the clinical education
- 54:41Speaker 16: and the posters and the keynote speakers, everything that people
- 54:43Speaker 16: have loved and they come to expect from us a
- 54:45Speaker 16: little bit some kind of party, right, but also, geez,
- 54:48Speaker 16: you know this is I've always believed that healthcare is.
- 54:51Speaker 4: Regional, right, so let's learn.
- 54:52Speaker 16: A little bit about the region where we're at.
- 54:53Speaker 3: Yeah, that's a really good point. I want to shout
- 54:56Speaker 3: out to your team. You have built the NASP into
- 54:59Speaker 3: something extremely special, very powerful. We need this, We need direction,
- 55:05Speaker 3: we need collaboration. I want to shout out to people listening.
- 55:08Speaker 3: If you're not involved with the NASP and you're in specialty,
- 55:12Speaker 3: get involved, because it's not just you, Sheila. It's not
- 55:16Speaker 3: just you and the team. It's your board, it's our vendors,
- 55:19Speaker 3: it's our specialists, it's people that understand technology and how
- 55:23Speaker 3: to leverage that. It's a community, and you've really built
- 55:26Speaker 3: a very strong community.
- 55:27Speaker 6: Oh my gosh.
- 55:28Speaker 9: I love that.
- 55:28Speaker 16: And it's our member volunteers, right, I have over I
- 55:31Speaker 16: think it's a tenth of our membership who volunteers in
- 55:33Speaker 16: some capacity on a committee. They help to put this
- 55:36Speaker 16: meeting together, the educational agenda of the workshops, right, all
- 55:39Speaker 16: of the things that we're doing. They provide ideas and feedback,
- 55:41Speaker 16: they serve as room bosses.
- 55:43Speaker 4: It's all of this.
- 55:43Speaker 3: We couldn't do it.
- 55:44Speaker 16: I have an amazing team six other people. But it's
- 55:46Speaker 16: six people, right, And it's incredible that these folks they're busy, right,
- 55:50Speaker 16: They're busy with their their professional practice or whatever, you know,
- 55:53Speaker 16: whatever part they play in this management of a specially patient.
- 55:57Speaker 3: They have personal lives.
- 55:58Speaker 16: Right, they have things going on, and they still devote
- 56:01Speaker 16: so much time and energy tonsp right, so selflessly yep,
- 56:04Speaker 16: raise their hand all the time.
- 56:05Speaker 6: And so I love that.
- 56:06Speaker 3: What I also love is that you've built an environment
- 56:10Speaker 3: inside specialty which can become very complex. And you've brought
- 56:14Speaker 3: in other associations like the American Pharmacists Association who participated here.
- 56:19Speaker 3: When you have those strong leadership groups coming together, it
- 56:22Speaker 3: makes noticeable changes. So I notice that and I value that.
- 56:27Speaker 16: Absolutely right. We're all here because of the patients that
- 56:30Speaker 16: we serve. Right, we want to make health care better.
- 56:32Speaker 16: I want to make health care better. I've been a
- 56:33Speaker 16: patient more times than I'd like to have been, right,
- 56:36Speaker 16: and you see where it's broken, but you also see
- 56:38Speaker 16: where it works, right, and so trying to foster that,
- 56:41Speaker 16: trying to bring these folks together so that they can
- 56:44Speaker 16: continue the discussions and the dialogue and make things better.
- 56:46Speaker 16: Like that's what I'm about, absolutely.
- 56:48Speaker 3: All right, Sheila, thank you for letting us be part
- 56:51Speaker 3: of this. We're so excited to have been here, and
- 56:54Speaker 3: we will see you in Denver.
- 56:55Speaker 8: Awesome.
- 56:56Speaker 16: Thank you so much, Todd for your partnership. People look
- 56:58Speaker 16: forward to this now.
- 56:59Speaker 8: Right.
- 56:59Speaker 16: Even I put a call out, hey, would you like
- 57:01Speaker 16: to be you know, on the episode of the you know,
- 57:03Speaker 16: our special episode from the annual meeting, Absolutely right, and
- 57:07Speaker 16: you see people flock over here, you know, and you're
- 57:09Speaker 16: embedded in our booth and we really appreciate you carbon
- 57:12Speaker 16: out the time to.
- 57:12Speaker 10: Be with us.
- 57:13Speaker 3: Absolutely, we'll be here, we'll continue to be here, all right,
- 57:16Speaker 3: We'll see you guys in Denver.
- 57:17Speaker 4: Awesome, thank you,